Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1M Hold
8,671,797
1.01% 28
2026
Q1
$12.9M Sell
8,671,797
-18,553,495
-68% -$28.2M 1.07% 27
2025
Q4
$35.9M Hold
27,225,292
2.32% 15
2025
Q3
$37.3M Hold
27,225,292
3% 10
2025
Q2
$38.4M Hold
27,225,292
3.93% 4
2025
Q1
$43.3M Hold
27,225,292
5.73% 3
2024
Q4
$96.4M Hold
27,225,292
10.8% 3
2024
Q3
$124M Hold
27,225,292
10.23% 2
2024
Q2
$115M Hold
27,225,292
10.66% 2
2024
Q1
$89.8M Buy
27,225,292
+3,081,611
+13% +$6.9M 7.06% 2
2023
Q4
$50.9M Buy
24,143,681
+7,619,047
+46% +$14.8M 4.17% 7
2023
Q3
$35M Hold
16,524,634
3.84% 8
2023
Q2
$53M Sell
16,524,634
-2,758,200
-14% -$7.85M 3.66% 6
2023
Q1
$41.8M Hold
19,282,834
2.9% 7
2022
Q4
$46.7M Buy
19,282,834
+4,044,739
+27% +$9.06M 5.37% 5
2022
Q3
$35.7M Hold
15,238,095
3.94% 8
2022
Q2
$23.6M Hold
15,238,095
2.37% 9
2022
Q1
$20.7M Buy
+15,238,095
New +$17M 1.43% 15

Other funds holding GERN

Vivo Capital's GERN Position: Q2 2026 in Review

Vivo Capital held its Geron (GERN) position steady in Q2 2026 at 8,671,797 shares worth $11.1M. The position accounts for 1.01% of the portfolio, ranked #28.

Vivo Capital first reported a position in GERN in Q1 2022 and has held it in 18 quarters since. The position peaked at $124M in Q3 2024. 259 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • Vivo Capital held 8,671,797 shares of Geron worth $11.1M as of Q2 2026.
  • Vivo Capital left its Geron share count unchanged in Q2 2026.
  • Geron made up 1.01% of Vivo Capital's portfolio in Q2 2026, its #28 holding.
  • Vivo Capital first reported a position in Geron in Q1 2022 and has held it in 18 quarters since.
  • Vivo Capital's Geron position peaked at $124M in Q3 2024.
  • 259 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on Vivo Capital's 13F filing for Q2 2026, filed 14 Aug 2026.